Frequent mutations in TP53 (n = 26, 81.3%) and ATRX (n = 20, 62.5%) were identified in astrocytomas (A), whereas no frequent mutations other than IDH1/2 were identified in oligodendrogliomas. This evidence concerns the gene ATRX and oligodendroglioma.